Found 6 matching trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
PHASE3Liprotamase powder is a non-porcine, soluble and stable mixture of biotechn...
Location
Investigator Site 139
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
N/AThis is a point prevalence study conducted entirely in the United States (U...
Location
Site Reference ID/Investigator# 116382
OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
PHASE2The primary objectives of this study are to assess the safety and efficacy ...
Location
Investigator Site 105
SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis
PHASE3Liprotamase powder is a non-porcine, soluble and stable mixture of three di...
Location
Investigator Site 123
SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis
PHASE3Liprotamase consists of 3 soluble, non-porcine digestive enzymes, lipase, p...
Location
Investigator Site 139
OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis
PHASE2The primary objectives of this study are to assess the safety and efficacy ...
Location
Investigator Site 105